The Pharmacist’s Evolving Role in Diabetes Management: The Power of Real-Time Continuous Glucose Monitoring

Details
Resources

The Pharmacist’s Evolving Role in Diabetes Management: The Power of Real-Time Continuous Glucose Monitoring

11:30 – 12:30 PM PST / 2:30 – 3:30 PM EST

A Dexcom presentation theater held in conjunction with APhA2021 Annual Meeting and Exposition, Virtual March 12-15.

This presentation will be available for viewing post livestream to SIGMA members on the SIGMA platform. If you are not already a member, we invite you to learn more about SIGMA or request membership to watch more educational webinars.

Pharmacist Toolkit PDF with FAQ

Personal CGM Playbook

LBL020301 2021 Voucher Brochure

LBL018917 Data Mining Flyer

LBL018785 Dexcom Start How to Prescribe Leave Behind2

LBL017084_Adhesive_supplements

LBL017085_irritated_or_sensitive_skin_Rev002

SIGMA Platform

BRIEF SAFETY STATEMENT

Failure to use the Dexcom G6 Continuous Glucose Monitoring System (G6) and its components according to the instructions for use provided with your device and available at https://www.dexcom.com/safety-information and to properly consider all indications, contraindications, warnings, precautions, and cautions in those instructions for use may result in you missing a severe hypoglycemia (low blood glucose) or hyperglycemia (high blood glucose) occurrence and/or making a treatment decision that may result in injury. If your glucose alerts and readings from the G6 do not match symptoms or expectations or you’re taking over the recommended maximum dosage amount of 1000mg of acetaminophen every 6 hours, use a blood glucose meter to make diabetes treatment decisions. Seek medical advice and attention when appropriate, including for any medical emergency.